Patients with SLE or APS are more susceptible to atherosclerotic cardiovascular events; immunological alterations, such as antibodies to oxidized LDL, aPLs, and antibodies to B2GPI, may have implications for premature atherosclerosis in SLE and APS.15 Here, APOH is linked to autoimmune polyendocrinopathy.